Partner IR & BD
Bioqube VenturesCheck size: Not publicly disclosed on the current official site.
Odile Rundquist is listed by Bioqube Ventures as Partner IR & BD. The profile is aligned to the firm's published thesis: Invests across stages and helps build therapeutics companies from inception through early clinical milestones.
Founders and companies that fit Bioqube Ventures's published focus: Bold science addressing major unmet medical needs with a credible path from discovery to medicines.
Opportunities outside Company creation, Seed, Early clinical or outside the firm's stated focus on Biotechnology, therapeutics, life sciences are less likely to fit the published mandate.
Use Bioqube Ventures's official founder contact route and lead with team credibility, the problem, traction, why now, and fit with Biotechnology, therapeutics, life sciences.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Current role verified on Bioqube Ventures's official roster. The official title is Partner IR & BD.